BMSD : 10.65048
BMSD : 10.65048
https://doi.org/10.65048/ijbmr
Search
About Us
Authors
Reviewers
Editorial Board
Contact Us

International Journal of Biological and Medical Research (IJBMR)

Original Article
Year : 2026  |  Volume : 17  |  Issue : 4  |  Page : 8741-8744 Full Version
A study of electrocardiographic changes, glycosylated haemoglobin (hba1c), and mean platelet volume in patients with type ii diabetes mellitus
Int J Biol Med Res. 2026; 17(4): 8741-8744  |  DOI: 10.65048/ijbmr.2026.17.4.8741.1081
Dr. M W. Pujari, *Dr. Nupur A Kulkarni
Department of Physiology, Prakash Institute of medical sciences and research centre, Uran, Ishwarpur, Dist- Sangli
*Department of Pathology, Prakash institute of medical sciences and research centre, Uran Ishwarpur, Dist-Sangli
Correspondence Address :
* Dr. Nupur A Kulkarni,
Department of Pathology,
Prakash institute of medical sciences and research centre.
Uran Ishwarpur, Dist-Sangli. E-mail: 88nupoor@gmail.com
Received: April 9, 2026 Accepted: July 6, 2026 Published: October 3, 2026

Abstract
Background: Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by persistent hyperglycaemia resulting from insulin resistance and/or impaired insulin secretion. Patients with T2DM are at increased risk of cardiovascular disease due to accelerated atherosclerosis and platelet hyperactivity. Mean Platelet Volume (MPV) reflects platelet size and activity and may serve as a simple marker for vascular risk. Glycated haemoglobin (HbA1c) represents long-term glycaemic control and predicts diabetic complications. The present study evaluated the association between MPV, HbA1c, and electrocardiographic (ECG) changes in patients with T2DM.
Materials and Methods: This cross-sectional case–control study included 100 patients with T2DM and 100 age- and sex-matched non-diabetic controls. Clinical evaluation, fasting blood sugar, HbA1c, MPV, and resting ECG were performed in all participants. MPV was measured using a BC-1800 haematology analyser, and HbA1c was estimated by the Dia zyme enzymatic method on a Selectra Junior autoanalyzer. Statistical analysis was performed using MS-Excel 2007 and GraphPad InStat software. Quantitative variables were analyzed using unpaired t-test and Wilcoxon signed-rank test, while qualitative variables were compared using z-test for proportion. A p value <0.05 was considered statistically significant.
Results: T2DM patients showed significantly higher blood sugar levels, HbA1c (9.31 ± 1.8 vs 5.6 ± 0.45), and MPV (9.08 ± 0.88 fL vs 8.09 ± 0.46 fL) compared with controls (p<0.0001). HbA1c demonstrated a significant positive correlation with duration of diabetes (p=0.0006). ECG abnormalities, including ST-segment depression, T-wave inversion, and pathological Q waves, were significantly more frequent in diabetic patients. Higher HbA1c and MPV values were observed among subjects with abnormal ECG findings.
Discussion: Elevated MPV in T2DM reflects enhanced platelet activation secondary to chronic hyperglycaemia, contributing to increased cardiovascular risk. The association of higher HbA1c and MPV with ECG changes suggests that these inexpensive and easily available investigations may help identify asymptomatic diabetic patients at risk for cardiovascular complications.
Keywords
Type 2 Diabetes Mellitus, Mean Platelet Volume, HbA1c, ECG Changes, Cardiovascular Risk.

Introduction

Diabetes mellitus is one of the most common chronic metabolic disorders worldwide and represents a major public health challenge. The global prevalence of diabetes has increased markedly in recent decades, particularly in developing countries [1]. Type 2 diabetes mellitus (T2DM) accounts for nearly 90–95% of cases and is characterized by insulin resistance, relative insulin deficiency, and chronic hyperglycaemia [2]. Persistent hyperglycaemia leads to long-term damage to organs such as the eyes, kidneys, nerves, and cardiovascular system [3]. Cardiovascular disease remains the leading cause of morbidity and mortality among diabetic patients [4], with a two- to four-fold higher risk of coronary artery disease compared to non-diabetics [5]. Platelet activation and endothelial dysfunction contribute significantly to vascular complications in diabetes [6]. Mean Platelet Volume (MPV) reflects platelet activity, while glycated haemoglobin (HbA1c) indicates long-term glycaemic control [5,7]. Electrocardiography is a simple method for detecting early cardiac abnormalities in diabetic patients [8]. This study evaluates ECG changes, HbA1c levels, and MPV in patients with Type 2 diabetes mellitus.

Materials and Method

The present study was designed as a cross-sectional case–control study conducted in the Department of Medicine of a tertiary care hospital. The study population consisted of 200 participants, including 100 patients diagnosed with Type 2 diabetes mellitus (cases) and 100 age- and sex-matched non-diabetic individuals (controls). All participants were recruited from the outpatient and inpatient departments of the hospital during the study period. Patients aged 30–70 years with a confirmed diagnosis of Type 2 diabetes mellitus according to established diagnostic criteria were included in the study. Only those patients who were willing to provide informed consent were enrolled. Individuals with known cardiovascular diseases unrelated to diabetes, haematological disorders affecting platelet indices, those taking antiplatelet drugs, and patients with renal failure or severe systemic illness were excluded from the study to avoid confounding factors that might influence platelet indices or electrocardiographic findings.

A detailed clinical history was obtained from each participant, including demographic information such as age, sex, duration of diabetes, presenting symptoms, and relevant medical history. This was followed by a thorough general physical examination and systemic examination to assess the overall clinical condition of the participants and to identify any signs suggestive of diabetic complications. All participants underwent laboratory investigations, which included fasting blood glucose, glycated haemoglobin (HbA1c), and mean platelet volume (MPV). Fasting blood glucose levels were measured using standard biochemical methods. HbA1c estimation was performed using the Diazyme enzymatic method on a Selectra Junior autoanalyzer, which reflects the average blood glucose levels over the preceding two to three months and is widely accepted as an indicator of long-term glycaemic control (15). Mean Platelet Volume (MPV) was measured using a BC-1800 automated haematology analyser, which determines platelet size and indirectly reflects platelet activation and function (47).In addition to laboratory investigations, a standard 12-lead resting electrocardiogram (ECG) was recorded for all participants to evaluate cardiac electrical activity and detect possible abnormalities. ECG findings were carefully analyzed for abnormalities including ST-segment depression, T-wave inversion, pathological Q waves, and conduction abnormalities. Interpretation of the electrocardiographic findings was performed according to established electrocardiographic criteria.The collected data were compiled and analyzed using MS-Excel 2007 and GraphPad InStat statistical software. Quantitative variables were expressed as mean ± standard deviation and compared using the unpaired t-test, while the Wilcoxon signed-rank test was applied where appropriate. Qualitative variables were analyzed using the z-test for proportion. A p-value less than 0.05 was considered statistically significant for all analyses.

Results

A total of 200 subjects were included in the study, comprising 100 patients with Type 2 diabetes mellitus (T2DM) and 100 age- and sex-matched non-diabetic controls. Comparative analysis of biochemical and electrocardiographic parameters was performed between the two groups. The fasting blood glucose levels were significantly higher among diabetic patients compared with the control group, confirming the hyperglycaemic status of the study population. Evaluation of glycated haemoglobin (HbA1c) levels revealed that the mean HbA1c value among diabetic patients was 9.31 ± 1.8%, whereas in the control group it was 5.6 ± 0.45%. This difference was found to be highly statistically significant (p < 0.0001), indicating poor long-term glycaemic control among the diabetic participants. Similarly, analysis of Mean Platelet Volume (MPV) showed significantly higher values in diabetic patients when compared with non-diabetic controls. The mean MPV among diabetic patients was 9.08 ± 0.88 fL, whereas the control group demonstrated a mean value of 8.09 ± 0.46 fL. The difference between the two groups was also statistically highly significant (p < 0.0001), suggesting increased platelet activation among individuals with diabetes mellitusFurther analysis demonstrated a significant positive correlation between HbA1c levels and the duration of diabetes (p = 0.0006). This finding indicates that patients with a longer duration of diabetes tended to have higher HbA1c levels, reflecting progressively poorer glycaemic control over time. Electrocardiographic evaluation revealed that ECG abnormalities were more frequently observed in diabetic patients compared with the control group. The most common abnormalities identified included ST-segment depression, T-wave inversion, and pathological Q waves. These electrocardiographic changes may suggest the presence of silent myocardial ischemia or early cardiovascular disease, which is commonly associated with long-standing diabetes mellites’ addition, when diabetic patients were categorized based on the presence or absence of ECG abnormalities, it was observed that individuals with abnormal ECG findings had comparatively higher HbA1c and MPV values than those with normal ECG findings. This association suggests that poor glycaemic control and increased platelet activity may contribute to the development of cardiovascular complications in patients with Type 2 diabetes mellitus. These findings highlight the potential role of HbA1c and MPV as useful indicators for identifying diabetic patients who may be at increased risk for cardiovascular disease.

Table 1: Demographic Characteristics of Study and Control Groups

Parameter

Study Group (n=100)

Control Group (n=100)

Sex Distribution

   

Male

58 (58%)

52 (52%)

Female

42 (42%)

48 (48%)

Age (years)

   

Mean ± SD

52.33 ± 8.79

49.41 ± 11.15

The study group comprised 100 participants, with males constituting 58% and females 42%. Similarly, the control group included 100 subjects, with 52% males and 48% females, indicating a comparable sex distribution between the two groups. The mean age of participants in the study group was 52.33 ± 8.79 years, while in the control group it was 49.41 ± 11.15 years, suggesting a slightly higher average age among the study population.

Table 2: Comparison of Anthropometric and Biochemical Parameters Between Study and Control Groups

 

Parameter

Study Group (Mean ± SD)

Control Group (Mean ± SD)

P value

Test Used

Height (HT)

158.64 ± 8.79

159.12 ± 12.70

P < 0.0001**

Wilcoxon Signed Rank Test

Weight (WT)

69.06 ± 9.26

59.59 ± 8.97

P < 0.0001**

Wilcoxon Signed Rank Test

Body Mass Index (BMI)

27.59 ± 3.07

23.77 ± 2.67

P < 0.0001**

Unpaired t-test

Blood Sugar Level (BSL)

236.63 ± 58.60

103.14 ± 15.94

P < 0.0001**

Wilcoxon Signed Rank Test

HbA1c

9.31 ± 1.8

5.6 ± 0.45

P < 0.0001**

Unpaired t-test

Mean Platelet Volume (MPV)

9.08 ± 0.88

8.09 ± 0.46

P < 0.0001**

Wilcoxon Signed Rank Test

Note:
P < 0.0001** indicates high statistical significance.
P < 0.05 is considered statistically significant.

Comparison of anthropometric and biochemical parameters between the study and control groups demonstrated statistically significant differences. The mean BMI of the study group (27.59 ± 3.07 kg/m²) was significantly higher than that of the control group (23.77 ± 2.67 kg/m²) when analyzed using the unpaired t-test (P < 0.0001). Blood sugar levels were markedly elevated in the study group (236.63 ± 58.60 mg/dL) compared with controls (103.14 ± 15.94 mg/dL), and this difference was statistically significant using the Wilcoxon Signed Rank test (P < 0.0001).Similarly, the mean HbA1c level was significantly higher in the study group (9.31 ± 1.8%) than in the control group (5.6 ± 0.45%) based on the unpaired t-test (P < 0.0001). Mean Platelet Volume (MPV) was also significantly increased in the study group (9.08 ± 0.88 fL) compared to controls (8.09 ± 0.46 fL), as determined by the Wilcoxon Signed Rank test (P < 0.0001). These findings indicate significantly higher BMI, glycaemic indices, and MPV among the study population compared with the control group.

Table 3: Comparison of ECG Changes Between Study and Control Groups

ECG Parameter

Study Group (n=100)

Control Group (n=100)

P value

ST Segment Changes

38 (38%)

12 (12%)

P < 0.0001**

T Wave Changes

42 (42%)

25 (25%)

P = 0.010*

Q–QS Pattern

12 (12%)

0 (0%)

P = 0.0004**

Note:
P < 0.0001** indicates high statistical significance.
P < 0.05 is considered statistically significant.

Electrocardiographic (ECG) abnormalities were significantly more prevalent in the study group compared to the control group. ST segment changes were observed in 38% of the study group versus 12% of controls, demonstrating high statistical significance (P < 0.0001). T wave abnormalities were present in 42% of the study group compared to 25% in the control group, which was also statistically significant (P = 0.010). Additionally, Q–QS pattern changes were noted in 12% of the study group, while none were observed in the control group, showing a highly significant difference (P = 0.0004).

All comparisons were performed using the Z test for proportions, indicating a significantly higher prevalence of ECG changes in the study population compared to controls.

Table 4: Correlation of HbA1c and MPV with Duration of Diabetes

Parameter

Correlation Coefficient (r)

P value

HbA1c vs Duration

0.33

0.0006**

MPV vs Duration

0.18

0.0593

Note:
P < 0.0001** indicates high statistical significance.
P < 0.05 is considered statistically significant.

There was a moderate positive correlation between duration of diabetes and HbA1c (r = 0.33), which was statistically significant (p = 0.0006), indicating that longer duration of diabetes is associated with higher HbA1c levels. In contrast, MPV showed a weak positive correlation with duration of diabetes (r = 0.18); however, this association was not statistically significant (p = 0.0593).

Table 5: Comparison of HbA1c and MPV in Relation to ECG Findings

Parameter

ECG Normal (Mean ± SD)

ECG Abnormal (Mean ± SD)

P value

HbA1c

8.56 ± 1.49

9.77 ± 1.84

0.0006**

MPV

8.88 ± 1.03

9.19 ± 0.79

0.12 (NS)

Note:
NS = Not significant.

The mean HbA1c level was significantly higher in subjects with abnormal ECG findings (9.77 ± 1.84) compared to those with normal ECG (8.56 ± 1.49), as determined by the unpaired t-test (p = 0.0006). This indicates a significant association between poor glycaemic control and ECG abnormalities.Although the mean MPV was higher in subjects with abnormal ECG (9.19 ± 0.79) compared to those with normal ECG (8.88 ± 1.03), the difference was not statistically significant (p = 0.12), suggesting no significant association between MPV and ECG changes in this study.

Discussion

Diabetes mellitus is associated with a significantly increased risk of cardiovascular disease, which remains the leading cause of mortality among diabetic patients. Early detection of cardiovascular risk factors is therefore essential. In the present study, diabetic patients showed significantly higher HbA1c levels compared to controls. This finding reflects poor glycaemic control and is consistent with previous studies that have demonstrated elevated HbA1c levels in diabetic patients [9]. HbA1c is widely used as a marker of long-term glycaemic control and has been shown to correlate with the risk of diabetic complications [10]. Higher HbA1c levels are associated with increased incidence of both microvascular and macrovascular complications. The present study also demonstrated significantly higher MPV values in diabetic patients compared with controls. MPV reflects platelet size and activity, and larger platelets are more reactive and thrombogenic [11]. Previous studies have reported increased MPV in diabetic patients and have suggested that MPV may serve as a marker of platelet activation and vascular risk [12, 13]. Hyperglycaemia can lead to increased platelet turnover and activation, contributing to the development of atherosclerosis and thrombosis. The association between elevated MPV and poor glycaemic control has been reported in several studies. Higher HbA1c levels are associated with increased platelet reactivity and increased risk of thrombotic events [14]. In the present study, ECG abnormalities were significantly more common among diabetic patients. These abnormalities included ST-segment depression, T-wave inversion, and pathological Q waves. Similar findings have been reported in previous studies that documented increased prevalence of ECG abnormalities among diabetic patients [13]. These changes may indicate silent myocardial ischemia or diabetic cardiomyopathy. Silent myocardial ischemia is particularly common in diabetic patients due to autonomic neuropathy, which may impair pain perception [15]. As a result, myocardial ischemia may remain undetected until advanced stages. The present study also demonstrated that patients with abnormal ECG findings had higher HbA1c and MPV values. This suggests that poor glycaemic control and increased platelet activation may contribute to cardiovascular complications in diabetic patients. Several mechanisms have been proposed to explain the increased cardiovascular risk in diabetes. Chronic hyperglycaemia leads to endothelial dysfunction, oxidative stress, and inflammation, all of which contribute to the development of atherosclerosis.

Platelet hyperactivity is another important factor in the pathogenesis of cardiovascular complications in diabetes. Increased platelet activation promotes thrombus formation and may lead to acute coronary events. The findings of the present study highlight the potential role of MPV and HbA1c as simple and cost-effective markers for identifying diabetic patients at increased risk of cardiovascular disease. Routine evaluation of HbA1c, MPV, and ECG may therefore help in early detection of cardiovascular complications in diabetic patients.

Conclusions

The present study demonstrated that patients with Type 2 diabetes mellitus have significantly higher HbA1c and Mean Platelet Volume compared with non-diabetic individuals. Electrocardiographic abnormalities were more common among diabetic patients, suggesting an increased risk of cardiovascular disease. A positive association was observed between HbA1c levels, MPV values, and ECG abnormalities. These findings suggest that MPV and HbA1c may serve as useful markers for identifying diabetic patients at risk for cardiovascular complications. Early detection and proper management of these risk factors may help reduce cardiovascular morbidity and mortality among diabetic patients.

References

[1] World Health Organization. Global report on diabetes. Geneva: WHO; 2016.
[2] Kaveeshwar SA, Cornwall J. The current state of diabetes mellitus in India. Australas Med J. 2014;7(1):45–48.
[3] Ramachandran A, Snehalatha C. Current scenario of diabetes in India. J Diabetes. 2009;1(1):18–28.
[4] Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ. Translating the A1C assay into estimated average glucose values. Diabetes Care. 2008;31(8):1473–1478.
[5] Schneider DJ. Factors contributing to increased platelet reactivity in people with diabetes. Diabetes Care. 2009;32(4):525–527.
[6] Bello-Sani F, Anumah FEO. Electrocardiographic abnormalities in persons with type 2 diabetes in Kaduna, Northern Nigeria. Int J Diabetes Metab.2009;17:99–103.
[7] Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar M. Significance of HbA1c test in diagnosis and prognosis of diabetic patients. Biomarker Insights.2016;11:95–104.
[8] Paulus JM. Platelet size in man. Blood. 1975;46(3):321–336.
[9] Kodiatte TA, Manikyam UK, Rao SB, Jagadish TM, Reddy M, Lingaiah HK, et al. Mean platelet volume in type 2 diabetes mellitus. J Lab Physicians. 2012;4(1):5–9.
[10] Chu SG, Becker RC, Berger PB, Bhatt DL, Eikelboom JW, Konkle B, et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J ThrombHaemost. 2010;8(1):148–156.
[11] Demirtunc R, Duman D, Basar M, Bilgi M, Teomete M, Garip T. The relationship between glycemic control and platelet activity in type 2 diabetes mellitus. J Diabetes Complications. 2009;23(2):89–94.
[12] Kittnar O. Electrocardiographic changes in diabetes mellitus. Physiol Res. 2015;64(Suppl 5):S559–S566.
[13] Menezes SA, Delasalle A, Arunachalam. A study of electrocardiographic changes in type 2 diabetic patients. Int J Res Med Sci. 2015;3(12):3470–3474.
[14] Tabibiazar R. Silent ischemia in people with diabetes: a condition that must be heard. Clin Diabetes. 2003;21(1):5–9.
[15] Fowler MJ. Microvascular and macrovascular complications of diabetes. Clin Diabetes. 2008;26(2):77–82


IJBMR -ISSN: 0976:6685. ©Copyright 2026 This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Published by BioMedSciDirect Publications